Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ghia

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
The British Journal of Radiology|July 20, 2022
Multidisciplinary management of spinal metastases: what the radiologist needs to knowSarah M Bahouth, Debra N Yeboa, Amol J Ghia, et al.
The British Journal of Radiology|August 10, 2022
Advances in the management of spinal metastases: what the radiologist needs to knowSarah M Bahouth, Debra N Yeboa, Amol J Ghia, et al.
Journal of Neuro-Oncology|July 13, 2023
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experienceJennifer K Matsui, Pamela K Allen, Haley K Perlow, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTENDAlexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 4, 2020
Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgeryKevin Diao, Juhee Song, Peter F Thall, et al.
Neuro-Oncology Practice|May 13, 2024
Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approachesThomas H Beckham, Michael K Rooney, Mary F McAleer, et al.
Journal of Neuro-Oncology|September 4, 2023
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgeryAlexander D Sherry, Sean Maroongroge, Brian De, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-upMatthew S Ning, Brian J Deegan, Jennifer C Ho, et al.
Advances in Radiation Oncology|August 11, 2020
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize RiskSonal S Noticewala, Ethan B Ludmir, Andrew J Bishop, et al.
Journal of Neurosurgery. Spine|February 15, 2020
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experienceDavid Boyce-Fappiano, Olsi Gjyshi, Todd A Pezzi, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
The British Journal of Radiology|July 20, 2022
Multidisciplinary management of spinal metastases: what the radiologist needs to knowSarah M Bahouth, Debra N Yeboa, Amol J Ghia, et al.
The British Journal of Radiology|August 10, 2022
Advances in the management of spinal metastases: what the radiologist needs to knowSarah M Bahouth, Debra N Yeboa, Amol J Ghia, et al.
Journal of Neuro-Oncology|July 13, 2023
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experienceJennifer K Matsui, Pamela K Allen, Haley K Perlow, et al.
International Journal of Radiation Oncology, Biology, Physics|June 12, 2022
Definitive Local Consolidative Therapy for Oligometastatic Solid Tumors: Results From the Lead-in Phase of the Randomized Basket Trial EXTENDAlexander D Sherry, Tharakeswara K Bathala, Suyu Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 4, 2020
Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgeryKevin Diao, Juhee Song, Peter F Thall, et al.
Neuro-Oncology Practice|May 13, 2024
Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approachesThomas H Beckham, Michael K Rooney, Mary F McAleer, et al.
Journal of Neuro-Oncology|September 4, 2023
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgeryAlexander D Sherry, Sean Maroongroge, Brian De, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-upMatthew S Ning, Brian J Deegan, Jennifer C Ho, et al.
Advances in Radiation Oncology|August 11, 2020
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize RiskSonal S Noticewala, Ethan B Ludmir, Andrew J Bishop, et al.
Journal of Neurosurgery. Spine|February 15, 2020
Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experienceDavid Boyce-Fappiano, Olsi Gjyshi, Todd A Pezzi, et al.
Pageof 12